PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.\', \'Department of Chemistry, University College London, London, UK.\', \'Institute for the Physics of Living Systems, University College London, London, UK.\', \'Institute of Structural and Molecular Biology, University College London, London, UK.\', \'Neurix SA, Geneva, Switzerland.\', \'School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland.\', \'Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland.\', \'Department of Pathology and Immunology, Faculty of Medicine, University of Geneva, Geneva, Switzerland. karl-heinz.krause@unige.ch.\', \'Division of Infectious Disease and Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland. karl-heinz.krause@unige.ch.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41598-021-91662-w
?:doi
?:hasPublicationType
?:journal
  • Scientific reports
is ?:pmid of
?:pmid
?:pmid
  • 34210996
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.533
?:rankingScore_hIndex
  • 122
?:title
  • Concurrent mutations in RNA-dependent RNA polymerase and spike protein emerged as the epidemiologically most successful SARS-CoV-2 variant.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all